David McAvoy

Track

Insider profile

Currently holds a position at Brickell Biotech Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Compliance Officer, General Counsel, Assistant Secretary Brickell Biotech Inc Aug. 31, 2019 -
David McAvoy's trades of Teva Pharmaceutical Industries Limited's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
0.84
Quantity 6,000 +inf%
Value US$5,039
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-09 2025-09-05
B Purchase
71,808 -11.5%
227.46
US$1,359,776 		71,808 -11.5% 227.46 US$1,359,776
2025-03-06 2025-03-05
PlS Planned sale
71,466 -8.1%
37.71
US$3,028,055 		71,466 -8.1% 37.71 US$3,028,055
2025-03-06 2025-03-04
PlS Planned sale
70,989 +46.9%
68.61
US$4,105,554 		70,989 +46.9% 68.61 US$4,105,554
2025-03-04 2025-03-04
PrS Proposed sale
4,827
16.00
US$77,232 		4,827 16.00 US$77,232
2025-03-04 2025-03-04
PrS Proposed sale
4,827
16.00
US$77,232 		4,827 16.00 US$77,232
2020-09-21 2020-09-18
B Purchase
6,000 +inf%
0.84
US$5,039 		6,000 +inf% 0.84 US$5,039
2020-09-21 2020-09-18
B Purchase
16,526 +27.8%
0.83
US$13,713 		16,526 +27.8% 0.83 US$13,713
2020-06-22 2020-06-22
B Purchase
30,435
0.00
US$0 		30,435 0.00 US$0